VR Logo

Thyrocare Technologies Ltd.

Add to My Investments

Healthcare | Health Services

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Activities of independent diagnostic/pathological laboratories

Incorporated: 2000

Chairman: A Velumani

Managing Director: A Velumani

Group: MNC

Listing: NSE: THYROCARE, BSE: 539871

Headquarters: Navi Mumbai, Maharashtra

Website: www.thyrocare.com

Key Facts

Market cap: R 4,036.96 Cr

Revenue (TTM): R 379.74 Cr

Earnings (TTM): R 61.10 Cr

Cash: R 80.10 Cr

Total Debt: R 2.50 Cr

Promoters' ownership: 66.04%

Liquidity: High

52 Week range: R 409.60 - 846.90

Face value: R10.00

Shares outstanding: 5,28,36,365

10 Years Aggregate:

  • CFO: 726.31 Cr
  • EBITDA: 970.48 Cr
  • Net Profit: 567.52 Cr

Stock Performance

Time Period Thyrocare Technologies S&P BSE Healthcare S&P BSE Small Cap
YTD39.2247.718.50
1 month1.802.89-0.85
3 months51.2420.3017.68
1 Year44.4355.9111.42
3 Years3.9613.94-2.30
5 Years--2.386.36
10 Years--12.693.75
As on 28-Sep-2020
Year Thyrocare Technologies S&P BSE Small Cap S&P BSE Healthcare
20191.86-6.85-3.55
2018-22.71-23.41-5.89
20170.8459.640.49